- Home
- CALC vs JDZG Comparison
CALC vs JDZG Comparison
Compare CALC & JDZG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- JDZG
- Stock Information
- Founded
- CALC 2011
- JDZG 2020
- Country
- CALC United States
- JDZG China
- Employees
- CALC N/A
- JDZG N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- JDZG Other Consumer Services
- Sector
- CALC Health Care
- JDZG Real Estate
- Exchange
- CALC Nasdaq
- JDZG Nasdaq
- Market Cap
- CALC 20.9M
- JDZG 18.4M
- IPO Year
- CALC N/A
- JDZG 2024
- Fundamental
- Price
- CALC $1.91
- JDZG $0.62
- Analyst Decision
- CALC Strong Buy
- JDZG
- Analyst Count
- CALC 3
- JDZG 0
- Target Price
- CALC $16.33
- JDZG N/A
- AVG Volume (30 Days)
- CALC 33.2K
- JDZG 530.5K
- Earning Date
- CALC 05-14-2025
- JDZG 05-27-2025
- Dividend Yield
- CALC N/A
- JDZG N/A
- EPS Growth
- CALC N/A
- JDZG N/A
- EPS
- CALC N/A
- JDZG 0.03
- Revenue
- CALC N/A
- JDZG $2,567,741.00
- Revenue This Year
- CALC N/A
- JDZG N/A
- Revenue Next Year
- CALC N/A
- JDZG N/A
- P/E Ratio
- CALC N/A
- JDZG $17.32
- Revenue Growth
- CALC N/A
- JDZG 20.36
- 52 Week Low
- CALC $1.43
- JDZG $0.45
- 52 Week High
- CALC $6.02
- JDZG $15.08
- Technical
- Relative Strength Index (RSI)
- CALC 56.52
- JDZG N/A
- Support Level
- CALC $1.86
- JDZG N/A
- Resistance Level
- CALC $2.04
- JDZG N/A
- Average True Range (ATR)
- CALC 0.14
- JDZG 0.00
- MACD
- CALC 0.05
- JDZG 0.00
- Stochastic Oscillator
- CALC 64.79
- JDZG 0.00
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About JDZG JIADE LIMITED Common stock
Jiade Ltd Ltd is engaged in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platforms and auxiliary solutions. The Group offers pre-enrollment guidance on school/selection and application development, training for entrance exams, and assistance in the application process. The Group also offers offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance in the People's Republic of China.